Surgery · Esophagus and Stomach Surgery (GERD, Carcinoma Stomach, Peptic Ulcer)

A 60-year-old man undergoes wedge resection of a 5 cm gastric tumour arising from the muscularis propria. Histology shows spindle cell neoplasm positive for CD117 and DOG1, negative for desmin and S100. Mitotic count is 8 per 50 high power fields. What is the most appropriate adjuvant management?

  • A No adjuvant therapy, surveillance only
  • B Adjuvant sunitinib 50 mg daily
  • C Adjuvant imatinib 400 mg daily
  • D Adjuvant FOLFOX chemotherapy
Correct answer: C. Adjuvant imatinib 400 mg daily

Explanation

CD117 (KIT) positivity identifies a gastrointestinal stromal tumour. Tumours larger than 5 cm with mitotic rate above 5 per 50 high power fields fall into a higher risk category, and adjuvant imatinib, a tyrosine kinase inhibitor against KIT, is indicated for at least 36 months. Sunitinib is second line for imatinib resistance, and conventional chemotherapy has no activity in GIST.

Reference: Schwartz's Principles of Surgery, 11th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Esophagus and Stomach Surgery (GERD, Carcinoma Stomach, Peptic Ulcer) MCQs

See all Esophagus and Stomach Surgery (GERD, Carcinoma Stomach, Peptic Ulcer) MCQs →